Components:
Method of action:
Medically reviewed by Militian Inessa Mesropovna, PharmD. Last updated on 21.03.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Liquifilm Tears 1.4% w/v eye drops, solution
Eye drops, solution
A clear, colourless solution.
As an ocular lubricant for the relief of dry eye and dry eye symptoms.
Dosage schedule: One to two drops as required or directed for all ages.
Route of administration: Topical instillation into conjunctival sac.
Hypersensitivity to the active substance or to any of the excipients.
Not for use with soft contact lenses.
If irritation, pain, redness and changes in vision occur or worsen or persist for more than 72 hours, treatment should be discontinued and a new assessment considered.
To avoid contamination, the dropper tip should not be allowed to touch the eye or any other surface.
Contact lenses should be removed before each application and may be reinserted after 15 minutes.
Liquifilm Tears contain benzalkonium chloride which is irritant to the eye and could cause discolouration of soft lenses. Avoid contact with soft contact lenses. Remove contact lenses before Liquifilm Tears is used and wait for at least 15 minutes before reinsertion.
Concomitant ocular medication should be administered 15 minutes prior to the instillation of Liquifilm Tears.
No studies on the effects on the ability to drive and use machines have been performed.
Based upon the information available, Liquifilm Tears has no or negligible influence on the ability to drive and use machines. However, it may cause transient blurring of vision. Do not drive or use hazardous machinery unless vision is clear.
The following undesirable effects have been reported since Liquifilm Tears was marketed.
Frequency:
Not known: the incidence cannot be determined from available information.
Eye disorders:
Not known: Eye irritation, eye pain, ocular hyperaemia, lacrimation increased, foreign body sensation, eye pruritus.
Immune system disorders:
Not known: hypersensitivity
No case of overdose has been reported.
Pharmacotherapeutic group: Artificial tears and other indifferent preparations, ATC code: S01AX20.
Not applicable. Liquifilm Tears contains no pharmacologically active ingredient.
Not applicable. Liquifilm Tears contains no pharmacologically active ingredient.
The constituents of Liquifilm Tears have been used safely in pharmaceutical products for many years. Topical administration in animal studies showed no untoward effects.
Sodium chloride
Sodium phosphate dibasic
Sodium phosphate monobasic
Benzalkonium chloride
Edetate disodium
Hydrochloric acid or sodium hydroxide (to adjust pH)
Purified water
None known.
24 months unopened.
Discard 28 days after opening.
Do not store above 25°C. Do not refrigerate or freeze.
Low density polyethylene (LDPE) bottle and tip and medium impact polystyrene (MIPS) screw cap. Safety seal to ensure integrity of the container.
Liquifilm Tears is available in 15ml bottles.
No special requirements.
Allergan Ltd
Marlow International
The Parkway
Marlow
Bucks
SL7 1YL
UK
PL 00426/0009R
Date of first authorisation: 19th September 1974
Date of latest renewal: 10th October 2005
15 July 2009
